Prostate‐specific membrane antigen (PSMA) is a type II, transmembrane glycoprotein that is highly expressed on prostate cancer epithelial cells as well as the endothelium of tumour‐associated neovasculature in non‐prostate cancers.9 Here, FOLH1 is linked to Familial prostate cancer.